The research, published in BMC Endocrine Disorders, was conducted by a team led by Etsegenet Yayut Munie and Melaku Taye Amogne of Addis Ababa University, working alongside collaborators at Monash University in Australia and Jimma University in Ethiopia. The investigators turned to Tikur Anbessa Specialized Hospital, a major urban tertiary referral center and university teaching hospital in Addis Ababa, to answer a deceptively simple question: among women diagnosed with gestational diabetes who delivered at the hospital, how many actually came back for postpartum diabetes screening within six months of giving birth? The answer, drawn from a careful retrospective review of medical records, was sobering.

The study design was methodical. The researchers identified 211 women who had been diagnosed with gestational diabetes and delivered at the hospital between January 2019 and January 2024, a five-year span that captured pre-pandemic and post-pandemic care alike. Using simple random sampling, they retrieved medical records from this cohort and abstracted the data with a standardized form, then analyzed everything in SPSS version 26. The primary outcome was straightforward: whether a woman completed a diabetes screening test within six months of delivery. The team also recorded postpartum glycemic status among those who were screened and used multivariable logistic regression to identify which factors independently predicted whether a woman would return for testing, reporting adjusted odds ratios with 95 percent confidence intervals.

The headline finding was that only 85 of the 211 women, or 40.3 percent, completed postpartum diabetes screening within the recommended six-month window. The women in the cohort had a mean age of 31.52 years, placing them squarely in the prime reproductive years, and yet the majority slipped through the follow-up net. In a setting where a tertiary referral hospital serves some of the best-resourced patients in the country, the authors note that screening uptake remained suboptimal even in this relatively favorable urban environment. If the best-connected patients in Ethiopia’s capital are missing follow-up testing at a rate of nearly 60 percent, the true national picture is likely worse.

What happened to the women who did return for testing adds urgency to the numbers. Among the 85 women screened, 20, or 23.5 percent, were diagnosed with type 2 diabetes at the time of testing, and another 20, also 23.5 percent, had prediabetes. Taken together, nearly half of the screened women had some form of dysglycemia, meaning abnormal blood glucose regulation, within months of giving birth. This is precisely the population in which early detection matters most: prediabetes can often be reversed with diet, physical activity, and weight management, while newly diagnosed type 2 diabetes in a young mother can be managed aggressively to protect her long-term health and her ability to care for her family.

The regression analysis revealed a clear pattern in who got screened and who did not. Women above 35 years of age were nearly five times more likely to complete postpartum screening than younger mothers, with an adjusted odds ratio of 4.97 and a 95 percent confidence interval of 1.54 to 16.0. Those who had a medical comorbidity during pregnancy, such as hypertension or another chronic condition compounding their gestational diabetes, had an adjusted odds ratio of 4.17, with a confidence interval of 1.80 to 9.68. The strongest single predictor was newborn birth weight: mothers whose babies weighed more than 4000 grams, a classic consequence of uncontrolled gestational diabetes, were more than eight times as likely to be screened, with an adjusted odds ratio of 8.63 and a confidence interval of 4.47 to 20.6.

Perhaps the most actionable finding concerned antenatal care. Women who attended eight or more antenatal care visits during pregnancy were almost six times more likely to return for postpartum diabetes screening, with an adjusted odds ratio of 5.98 and a 95 percent confidence interval of 2.52 to 14.19. This makes intuitive sense from a health-systems perspective: every antenatal visit is an opportunity for clinicians to explain why follow-up testing matters, to book the appointment before the woman leaves the hospital, and to build the trust and familiarity that bring patients back. The finding suggests that the postpartum screening gap is not primarily a problem of patient motivation but of missed opportunities during pregnancy and the immediate postpartum period, when contact with the health system is at its peak.

The biological logic behind postpartum screening is worth spelling out. Gestational diabetes arises when the hormonal environment of pregnancy, which includes placental hormones that antagonize insulin, overwhelms a woman’s pancreatic capacity to compensate. In most women, glucose tolerance normalizes after delivery, but the underlying vulnerability often does not. Longitudinal research worldwide has shown that women with prior gestational diabetes progress to type 2 diabetes at rates many times higher than the general female population, and the risk is highest in the first few years after delivery. The Ethiopian data, showing that nearly half of screened women already had abnormal glucose within six months, underscores how quickly that transition can occur and how little time there is to intervene.

The study’s implications reach well beyond one hospital in Addis Ababa. The International Diabetes Federation has documented the rising burden of diabetes across sub-Saharan Africa, where urbanization, changing diets, and declining physical activity are driving a quiet epidemic that intersects with maternal health. Gestational diabetes serves as an early warning system for this epidemic: every affected pregnancy identifies a woman at high risk who could benefit from years of preventive care. When screening uptake is only 40 percent, the health system loses most of that early-warning capacity, and women who could have been treated early instead present years later with established disease, complications, and higher costs for families and the public purse.

The authors are careful about what their retrospective, single-institution design can and cannot show. Chart reviews depend on the completeness of medical documentation, and the study reflects the experience of one urban tertiary center rather than the country as a whole, so the findings cannot simply be generalized to rural Ethiopia where access to care is far more limited. Still, the direction of the evidence is clear, and the research team calls for prospective studies to evaluate implementation strategies that could lift screening rates. The most promising approaches suggested by the antenatal care finding include embedding screening orders and reminders into routine postpartum care, using electronic medical records to flag women due for testing, and educating women during pregnancy about the lifelong importance of that single follow-up blood test. For the nearly 60 percent of women in this study who never got screened, and the undiagnosed cases of diabetes and prediabetes among them, such system-level fixes are not a luxury. They are the difference between catching a disease in time and missing it entirely.

Subject of Research: Postpartum diabetes screening uptake among women with prior gestational diabetes in Ethiopia

Article Title: Uptake of postpartum diabetes screening after gestational diabetes: a five-year institution-based retrospective study in Ethiopia

Article References: Munie, E. Y., Reja, A., Lim, S., Boyle, J., Arage, S., Mulisa, M. D., Wondie, E. M., Getachew, B., Gichamo, F. G., & Amogne, M. T. (2026). Uptake of postpartum diabetes screening after gestational diabetes: a five-year institution-based retrospective study in Ethiopia. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-026-02626-y

Image Credits: AI Generated

DOI: 10.1186/s12902-026-02626-y

Keywords: gestational diabetes, postpartum screening, type 2 diabetes, prediabetes, Ethiopia, maternal health, antenatal care, screening uptake, dysglycemia, retrospective study, global health, endocrinology

The research team, led by Leen Ghanim of Al-Quds Bard College and Alhareth M. Amro of the Faculty of Medicine at Al-Quds University, with collaborators from Hebron University, An-Najah National University and Jordan University of Science and Technology, set out to measure three intertwined variables: knowledge of cervical cancer, attitudes toward its prevention, and self-reported screening history. Palestine is a particularly important setting for this kind of investigation because, unlike many high-income countries, it lacks an organized, population-based cervical cancer screening program. In the absence of systematic invitations, reminders and registry-based follow-up, screening depends almost entirely on women seeking it out on their own initiative or on a clinician recommending it during an unrelated visit — a model that the new data suggest is failing most of the population.

The study was conducted between November and December 2025 using an online, self-administered questionnaire adapted from a previously published knowledge, attitudes and practices instrument and modified to fit the Palestinian context. Participants answered items covering sociodemographic characteristics, cervical cancer knowledge, attitudes toward screening, and whether they had ever been screened. The scoring system was deliberately simple and transparent: each knowledge item earned one point for a correct answer and zero for an incorrect answer, a “don’t know” response or a refusal, producing a maximum knowledge score of 32. Attitude items were scored the same way, with medically appropriate responses earning one point each, for a maximum of 8. This dichotomous approach allowed the researchers to quantify both how much women knew and how favorably they viewed prevention, and then to test whether either measure predicted actual screening behavior.

The results revealed a sobering asymmetry. The mean knowledge score was 9.7 out of a possible 32, with a standard deviation of 7.2 — a figure that indicates substantial and widespread gaps in understanding of cervical cancer, its causes and its preventability. Yet the mean attitude score was 5.45 out of 8, with a standard deviation of 2.01, suggesting that most participants held generally favorable views toward cervical cancer prevention. In other words, Palestinian women in this sample were not resistant to the idea of screening; they were simply underinformed about it. The two scores were moderately correlated, meaning that women who knew more about the disease also tended to hold more favorable attitudes, but knowledge and attitudes clearly operated on different levels of the behavioral pathway.

That distinction became even more consequential when the researchers turned to multivariable logistic regression, a statistical technique that estimates the independent effect of each factor while holding all the others constant. In this analysis, four variables emerged as independently associated with self-reported previous screening: older age, marital status, higher educational level and a higher knowledge score. Notably, the attitude score was not independently associated with screening uptake once these other factors were accounted for. The implication is striking — good intentions and positive attitudes toward prevention do not translate into action unless they are anchored by concrete knowledge and by demographic circumstances that bring women into contact with the health system.

The role of age and marital status fits with what is known about how screening is delivered in settings without organized programs. Older women are more likely to have had routine gynecological encounters, pregnancies, or other healthcare interactions during which a provider might raise the topic of cervical screening, and married women similarly accumulate more contact points with reproductive health services. Education, meanwhile, shapes both health literacy and the confidence to navigate a fragmented healthcare landscape. But the strongest modifiable signal in the data is knowledge itself: women who scored higher on the 32-point knowledge scale were significantly more likely to report having been screened, which positions education as the most actionable lever available to Palestinian health authorities.

From a technical standpoint, the study’s design carries both strengths and limitations that readers should keep in mind. The cross-sectional, online format means the sample skews toward women with internet access and the inclination to complete a survey, so the true national picture could differ. Self-reported screening history is also vulnerable to recall bias and to confusion between cervical screening and other gynecological examinations, a problem that is amplified when general knowledge of what a Pap test or HPV test actually involves is low. The authors themselves frame the work as evidence-generating for health-promotion strategy rather than a definitive prevalence estimate, and the questionnaire’s adaptation from a validated instrument, along with ethics approval from Al-Quds University’s Research Ethics Committee and electronic informed consent from all participants, gives the findings a solid methodological footing within those constraints.

The public health stakes are considerable. Cervical cancer is driven overwhelmingly by persistent infection with high-risk types of human papillomavirus, and decades of evidence from countries with organized programs show that regular screening can catch precancerous lesions years before they become invasive, rendering the disease one of the most survivable cancers when detected early. The World Health Organization’s global strategy for cervical cancer elimination rests on three pillars — vaccination, screening and treatment of precancerous lesions — and countries without structured screening programs consistently report low uptake, late-stage diagnosis and preventable deaths. The Palestinian data add a granular, locally grounded data point to that global picture, quantifying exactly how wide the gap is between favorable attitudes and actual preventive behavior when no system exists to close it.

The authors’ conclusion points toward a practical remedy rooted in primary healthcare. Because higher knowledge was the key modifiable predictor of screening, they argue for health-promotion strategies embedded in primary care settings that improve cervical-cancer-specific knowledge, clarify the purpose of preventive screening — distinguishing it from examinations for symptoms — and encourage providers to recommend screening during routine healthcare encounters. Provider-led recommendation is a low-cost intervention with demonstrated effect in other low-resource settings, and it could compensate for the absence of organized invitation systems. Marital status and age, being non-modifiable, instead help identify which groups to target: outreach could prioritize younger and unmarried women who currently have the fewest natural touchpoints with screening services.

What makes this study resonate beyond Palestine is the clarity of its central lesson: attitudes are not the bottleneck. Women in the survey were broadly receptive to the idea of preventing cervical cancer, but without knowledge of why, when and how to be screened — and without a clinician or a system prompting them — that receptiveness remained dormant. For health systems across the region and in other settings without organized screening, the message is that information campaigns and provider training may deliver more screening uptake per dollar than campaigns aimed at changing opinions. As the global community pursues the WHO’s elimination targets, evidence like this underscores that the final mile of cancer prevention is often not a matter of technology or will, but of making sure every woman knows that a simple, life-saving test exists and is invited to take it.

Subject of Research: Cervical cancer screening knowledge, attitudes and uptake among women in Palestine

Article Title: Knowledge, attitudes, and factors associated with cervical cancer screening uptake among women in Palestine: a cross-sectional study

Article References: Ghanim, L., Musa, B., Massarwa, R., Mosleh, I., Manadre, S., Bari, A., Haj, N., Bozia, Y., Shqerat, H., Bakhtan, S., Alsheqerat, H., Deeb, S., & Amro, A. M. (2026). Knowledge, attitudes, and factors associated with cervical cancer screening uptake among women in Palestine: a cross-sectional study. Discover Social Science and Health. https://doi.org/10.1007/s44155-026-00458-8

Image Credits: AI Generated

DOI: 10.1007/s44155-026-00458-8

Keywords: cervical cancer, cancer screening, Palestine, women's health, human papillomavirus, health knowledge, screening uptake, cross-sectional study, cancer prevention, primary healthcare, public health, health promotion

The review, led by Nanik Setiyawati with Sri Sulistyowati and Heru Priyanto, analysed twenty-one original intervention and implementation studies spanning Argentina, Nepal, India, the United States, Kenya, Nigeria, Uganda, Tanzania, Ethiopia, Iran, Malaysia and Hong Kong. Rather than pooling effect sizes, the researchers charted who delivered each intervention, where screening access was created, how cultural barriers were addressed and whether participants were connected to follow-up care. This implementation-focused lens matters because a programme labelled a “home visit” can mean radically different things: one visit may merely encourage clinic attendance, while another offers HPV self-collection on the spot, transports the specimen and arranges follow-up for abnormal results.

From the evidence map, six recurring strategy families emerged: lay or peer workforce models, culturally tailored education, navigation and barrier reduction, HPV self-sampling, mobile health reminders and integrated community outreach. The most successful programmes combined several of these functions. In Argentina’s EMA cluster-randomised trial, community health workers offering HPV self-collection during home visits achieved an HPV testing rate of 86 percent compared with 20 percent in the control arm, a risk ratio of 4.02. In Hong Kong, a community health worker-led programme combining education, monthly phone calls and navigation for South Asian women reached 97.9 percent screening uptake at three months versus 52.6 percent among controls.

The numbers from low- and middle-income settings are equally compelling. In Nepal, female community health volunteers who provided home education, referral and follow-up raised screening uptake by 48 percent relative to control. In rural India, a nurse-led multicomponent intervention lifted Pap testing from 4.1 percent at baseline to 71.5 percent within six months. In Nigeria, women offered HPV self-collection in their community achieved 93 percent screening completion compared with 56 percent for hospital-based collection, and nearly all returned specimens were adequate for testing. In the United States, mailed HPV self-collection kits plus scheduling assistance more than doubled uptake among under-screened low-income women, reaching 72 percent versus 37 percent.

Digital tools added measurable value when they addressed concrete barriers. In Tanzania, a randomised double-blind trial found that behaviour-change text messages tripled attendance compared with a single informational message, and adding a transport eVoucher nearly doubled the effect again, pushing the odds ratio to 4.7. That combination worked because it tackled both the behavioural hesitation and the financial cost of reaching a clinic. Yet the review is careful to note that SMS strategies depend on phone access, privacy, literacy and local service capacity, which is why eligibility for the Tanzanian trial itself required mobile-phone ownership.

Perhaps the review’s most important contribution is its insistence on framing screening promotion as a prevention cascade: engagement, communication, access, screening completion, result delivery, triage and treatment linkage. When the authors traced participants beyond the first test, troubling gaps appeared. In rural Kenya, community health campaigns raised population-level screening uptake to 60 percent versus 37 percent for facility-based delivery, but treatment acquisition among HPV-positive women remained low in both arms, at roughly 39 percent and 31 percent with no statistically significant difference. In Uganda, a community self-sampling programme achieved 82 percent participation, yet only 35 percent of women who tested positive for high-risk HPV and received SMS instructions actually attended follow-up, with transport costs, disbelief, childcare burdens and the absence of symptoms all cited as barriers.

These downstream failures carry a hard lesson for policymakers: a first screening test is an intermediate milestone, not the finish line. The review argues that programmes should begin with the least-screened population and specify a complete pathway from trust to treatment linkage, identifying who delivers the message, how cultural and language barriers are addressed, which screening route is offered, how results are communicated and how positive findings are followed up. Education alone, the evidence shows, is often insufficient. Two included trials, one in Hong Kong and one in Kenya, improved knowledge or beliefs without producing a clear screening uptake advantage, underscoring the distinction between changing minds and changing access.

The review also exposes persistent reporting deficiencies that limit how transferable these models are. Uptake was commonly reported, but fidelity to the intervention design, cost, workforce training, equity reach, participant burden, result notification, triage and long-term sustainability were inconsistently documented. Although many studies intentionally recruited rural, low-income, ethnic-minority or safety-net populations, few reported stratified data on who actually completed screening, received results or reached follow-up care across intersecting barriers. A Ugandan cost-effectiveness analysis built on the ASPIRE trial suggested that HPV screen-and-treat could reduce lifetime cervical cancer risk from 4.2 percent to as low as 2.4 percent with repeated screening, at incremental costs of roughly US$130 to US$470 per year of life saved, but those estimates hinge on test costs, treatment linkage and modelled assumptions.

The practical prescription that emerges is to match the intervention to the documented barrier profile of a community. Where mistrust or language barriers dominate, culturally concordant messengers such as community health workers, promotoras and lay health advisors supply relational trust and local legitimacy. Where access barriers dominate, self-sampling, local campaigns, worksite programmes and navigation can physically move the screening opportunity closer to the people who need it. Where downstream retention is weak, result-delivery systems and treatment navigation become the priority investment. The authors acknowledge limitations, including reliance on open bibliographic records, incomplete exclusion-reason logging and heterogeneous study designs that preclude meta-analysis, but the pattern across twenty-one studies is consistent enough to guide programme design today.

As the world pursues the World Health Organization’s cervical cancer elimination targets, this evidence map reframes what success looks like. Getting a woman to complete a screening test matters enormously, but the true measure of a community-based programme is whether she then receives her result, attends follow-up if the test is abnormal and obtains treatment when needed. Programmes that connect trusted community interfaces with feasible screening routes and reliable aftercare, the review concludes, are the ones positioned to convert screening activity into genuine cancer prevention, and future evaluations should report cascade completion and implementation conditions rather than celebrating uptake numbers alone.

Subject of Research: Community-based health promotion strategies to increase uptake of cervical cancer screening

Article Title: Mapping community-based health promotion strategies for cervical cancer screening uptake: A scoping review of intervention components, delivery models and implementation gaps

Article References: Setiyawati, N., Sulistyowati, S., & Priyanto, H. (2026). Mapping community-based health promotion strategies for cervical cancer screening uptake: A scoping review of intervention components, delivery models and implementation gaps. Public Health in Practice, 12, Article 100857. https://doi.org/10.1016/j.puhip.2026.100857

Image Credits: AI Generated

DOI: 10.1016/j.puhip.2026.100857

Keywords: cervical cancer screening, HPV self-sampling, community health workers, health promotion, prevention cascade, patient navigation, SMS reminders, scoping review, global health equity, cancer elimination, public health in practice, screening uptake